ITA reduces your financial exposure by improving medical outcomes

Direct treatment costs for cancer exceed $93 billion a year, according to the National Institutes of Health.

Cancer care averages $90,000 per patient — high enough to demand that you know you’re paying for evidence-based medicine.  You need experts who:

• validate prescribed care meets proven standards and is followed;
• manage side effects, co-morbidities, and disease progression;
• coordinate treatment across medical specialties; and
• affirm drugs, therapies, and diagnostics are used and priced appropriately.